SC

Singanamala Charan Vinith

Active Director Director DIN 09294450
DIN 09294450 First appointment Aug 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Singanamala Charan Vinith

Data last updated:

Singanamala Charan Vinith is a Director at Skanda Hospital Private Limited (since 2021). The company operates in Healthcare.

DIN 09294450
Primary Designation Director
Industry Healthcare
First Appointment 26 Aug 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Skanda Hospital Private Limited U85100AP2021PTC119228
Director26 Aug 20212021Active

Board colleagues of Singanamala Charan Vinith

NameDINCompanyDesignation
Sarepakkam Krithika Sakthi09294451Skanda Hospital Private LimitedDirector

Directorship timeline

Open interactive timeline →
Skanda Hospital Private Limited
Premium access

Shareholding and investment profile for Singanamala Charan Vinith

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Singanamala Charan Vinith

Singanamala Charan Vinith currently holds 1 directorship: Skanda Hospital Private Limited (Director, since 26 Aug 2021).

Singanamala Charan Vinith was first appointed on 26 Aug 2021 as Director at Skanda Hospital Private Limited.

The current boards of Singanamala Charan Vinith's companies include Sarepakkam Krithika Sakthi (Skanda Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available